Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2025-12-30 @ 3:15 AM
Study NCT ID:
NCT05534061
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2022-09-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Motivation, Syringe Exchange, and COVID-19
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000086382', 'term': 'COVID-19'}], 'ancestors': [{'id': 'D011024', 'term': 'Pneumonia, Viral'}, {'id': 'D011014', 'term': 'Pneumonia'}, {'id': 'D012141', 'term': 'Respiratory Tract Infections'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018352', 'term': 'Coronavirus Infections'}, {'id': 'D003333', 'term': 'Coronaviridae Infections'}, {'id': 'D030341', 'term': 'Nidovirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'amariem@uoregon.edu', 'phone': '602-920-7459', 'title': 'Anne Marie Mauricio, PhD', 'organization': 'University of Oregon'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': 'Adverse event data was collected from completion of randomization through the 9-month follow-up period.', 'eventGroups': [{'id': 'EG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients', 'otherNumAtRisk': 177, 'deathsNumAtRisk': 177, 'otherNumAffected': 0, 'seriousNumAtRisk': 177, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients', 'otherNumAtRisk': 172, 'deathsNumAtRisk': 172, 'otherNumAffected': 0, 'seriousNumAtRisk': 172, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'SARS-CoV-2 Testing', 'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'OG000'}, {'value': '172', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'OG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}], 'classes': [{'categories': [{'title': 'Was tested', 'measurements': [{'value': '54', 'groupId': 'OG000'}, {'value': '53', 'groupId': 'OG001'}]}, {'title': 'Was not tested', 'measurements': [{'value': '123', 'groupId': 'OG000'}, {'value': '119', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '.944', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Odds Ratio (OR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.98', 'ciLowerLimit': '0.62', 'ciUpperLimit': '1.56', 'pValueComment': 'A priori threshold for statistical significance was p\\<.05.', 'estimateComment': 'Contingency Management Alone coded as the reference group.', 'statisticalMethod': 'Regression, Logistic', 'nonInferiorityType': 'SUPERIORITY', 'statisticalComment': 'A multilevel logistic regression model was specified.'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Immediate post intervention (i.e., same day)', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'SARS-CoV-2 Testing', 'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'OG000'}, {'value': '172', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'OG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}], 'classes': [{'categories': [{'title': 'Was tested', 'measurements': [{'value': '46', 'groupId': 'OG000'}, {'value': '46', 'groupId': 'OG001'}]}, {'title': 'Was not tested', 'measurements': [{'value': '131', 'groupId': 'OG000'}, {'value': '126', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '.952', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Odds Ratio (OR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '1.01', 'ciLowerLimit': '0.62', 'ciUpperLimit': '1.65', 'pValueComment': 'A priori threshold for statistical significance was p\\<.05.', 'estimateComment': 'Contingency Management Alone coded as the reference group.', 'statisticalMethod': 'Regression, Logistic', 'nonInferiorityType': 'SUPERIORITY', 'statisticalComment': 'A multilevel logistic regression model was specified.'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to 9-months after intervention', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'COVID-19 Vaccination', 'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'OG000'}, {'value': '172', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'OG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}], 'classes': [{'title': 'Was vaccinated', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}]}]}, {'title': 'Was not vaccinated', 'categories': [{'measurements': [{'value': '168', 'groupId': 'OG000'}, {'value': '164', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '.768', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Odds Ratio (OR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '1.16', 'ciLowerLimit': '0.43', 'ciUpperLimit': '3.11', 'pValueComment': 'A priori threshold for statistical significance was p\\<.05.', 'estimateComment': 'Contingency Management Alone coded as the reference group.', 'statisticalMethod': 'Regression, Logistic', 'nonInferiorityType': 'SUPERIORITY', 'statisticalComment': 'A multilevel logistic regression model was specified.'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Immediate post intervention (i.e., same day)', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'COVID-19 Vaccination', 'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'OG000'}, {'value': '172', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'OG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}], 'classes': [{'categories': [{'title': 'Was vaccinated', 'measurements': [{'value': '19', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}]}, {'title': 'Was not vaccinated', 'measurements': [{'value': '158', 'groupId': 'OG000'}, {'value': '167', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '.008', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Odds Ratio (OR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '3.96', 'ciLowerLimit': '1.43', 'ciUpperLimit': '10.94', 'pValueComment': 'A priori threshold for statistical significance was p\\<.05.', 'estimateComment': 'Contingency Management Alone coded as the reference group.', 'statisticalMethod': 'Regression, Logistic', 'nonInferiorityType': 'SUPERIORITY', 'statisticalComment': 'A multilevel logistic regression model was specified.'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Up to 9-months after intervention', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'FG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '177'}, {'groupId': 'FG001', 'numSubjects': '172'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '177'}, {'groupId': 'FG001', 'numSubjects': '172'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '177', 'groupId': 'BG000'}, {'value': '172', 'groupId': 'BG001'}, {'value': '349', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'BG001', 'title': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.\n\nConnect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '42.60', 'spread': '11.23', 'groupId': 'BG000'}, {'value': '45.19', 'spread': '10.80', 'groupId': 'BG001'}, {'value': '43.92', 'spread': '11.11', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex/Gender, Customized', 'classes': [{'title': 'Female', 'categories': [{'measurements': [{'value': '53', 'groupId': 'BG000'}, {'value': '51', 'groupId': 'BG001'}, {'value': '104', 'groupId': 'BG002'}]}]}, {'title': 'Male', 'categories': [{'measurements': [{'value': '89', 'groupId': 'BG000'}, {'value': '88', 'groupId': 'BG001'}, {'value': '177', 'groupId': 'BG002'}]}]}, {'title': 'Non-binary', 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}]}]}, {'title': 'Bigender', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}]}]}, {'title': 'None of the listed categories', 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '31', 'groupId': 'BG000'}, {'value': '25', 'groupId': 'BG001'}, {'value': '56', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '6', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '14', 'groupId': 'BG002'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '5', 'groupId': 'BG002'}]}, {'title': 'Black or African American', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}]}, {'title': 'White', 'measurements': [{'value': '109', 'groupId': 'BG000'}, {'value': '113', 'groupId': 'BG001'}, {'value': '222', 'groupId': 'BG002'}]}, {'title': 'More than one race', 'measurements': [{'value': '8', 'groupId': 'BG000'}, {'value': '11', 'groupId': 'BG001'}, {'value': '19', 'groupId': 'BG002'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '50', 'groupId': 'BG000'}, {'value': '31', 'groupId': 'BG001'}, {'value': '81', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'Hispanic', 'categories': [{'measurements': [{'value': '13', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '27', 'groupId': 'BG002'}]}]}, {'title': 'Non-Hispanic', 'categories': [{'measurements': [{'value': '92', 'groupId': 'BG000'}, {'value': '88', 'groupId': 'BG001'}, {'value': '180', 'groupId': 'BG002'}]}]}, {'title': 'Unknown or Not Reported', 'categories': [{'measurements': [{'value': '72', 'groupId': 'BG000'}, {'value': '70', 'groupId': 'BG001'}, {'value': '142', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2022-07-26', 'size': 308943, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_002.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2024-01-03T17:49', 'hasProtocol': True}, {'date': '2022-07-26', 'size': 126291, 'label': 'Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'SAP_003.pdf', 'typeAbbrev': 'SAP', 'uploadDate': '2024-01-03T17:49', 'hasProtocol': False}, {'date': '2022-08-08', 'size': 237420, 'label': 'Informed Consent Form', 'hasIcf': True, 'hasSap': False, 'filename': 'ICF_004.pdf', 'typeAbbrev': 'ICF', 'uploadDate': '2024-01-03T17:50', 'hasProtocol': False}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'FACTORIAL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 349}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2022-08-08', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-01', 'completionDateStruct': {'date': '2023-06-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2024-01-30', 'studyFirstSubmitDate': '2022-09-07', 'resultsFirstSubmitDate': '2023-11-27', 'studyFirstSubmitQcDate': '2022-09-07', 'lastUpdatePostDateStruct': {'date': '2024-02-28', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2024-01-30', 'studyFirstPostDateStruct': {'date': '2022-09-09', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2024-02-28', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-06-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'SARS-CoV-2 Testing', 'timeFrame': 'Immediate post intervention (i.e., same day)', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record'}, {'measure': 'SARS-CoV-2 Testing', 'timeFrame': 'Up to 9-months after intervention', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record'}], 'secondaryOutcomes': [{'measure': 'COVID-19 Vaccination', 'timeFrame': 'Immediate post intervention (i.e., same day)', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records'}, {'measure': 'COVID-19 Vaccination', 'timeFrame': 'Up to 9-months after intervention', 'description': 'Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['COVID-19 Pandemic']}, 'descriptionModule': {'briefSummary': 'People who inject drugs (PWIDs) are highly vulnerable to SARS-CoV-2 infection and to the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), however, rates of SARS-CoV-2 testing and vaccination uptake -vital to mitigating the spread of COVID-19 and achieving herd immunity - are lower among PWIDs compared to the general population. Building on our Phase I Rapid Acceleration of Diagnostics project, which found that contingency management (CM) increased testing utilization among PWIDs, the proposed project evaluates the comparative effectiveness of CM versus CM plus a brief motivational enhancement intervention on SARS-CoV-2 testing and vaccination uptake among PWIDs. This project has the potential to reduce COVID-19 health disparities among PWIDs and to decrease population level COVID-19 morbidity and mortality.', 'detailedDescription': 'This study uses contingency management, specifically $10 financial incentives for participation in SARS-CoV-2 testing and $10 for participating in COVID-19 vaccination. It also uses a motivational enhancement intervention which is a brief conversation with clients to improve intrinsic motivation for testing and vaccination. Thus, the clinical trials portion of this study is a randomized control trial (N = 349) in which 177 participants will be assigned to contingency management plus the Connect2Test intervention and 172 will be assigned to the contingency management alone (i.e. services as usual). There will be a per site quota to ensure there are relatively equivalent numbers of participants per site to avoid site-specific biases. The data collection software (e.g., Qualtrics, PowerBI) will randomly assign individuals to condition in real time, after a participant consents to participate in the study.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* 18 and older, understand English\n\nExclusion Criteria:\n\n* none'}, 'identificationModule': {'nctId': 'NCT05534061', 'briefTitle': 'Motivation, Syringe Exchange, and COVID-19', 'organization': {'class': 'OTHER', 'fullName': 'University of Oregon'}, 'officialTitle': 'Motivational Enhancement to Augment Contingency Management for SARS-CoV-2 Testing and Vaccination Utilization Among Syringe Exchange Clients', 'orgStudyIdInfo': {'id': '11162020.013b'}, 'secondaryIdInfos': [{'id': '1U01DA055982-01', 'link': 'https://reporter.nih.gov/quickSearch/1U01DA055982-01', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Connect2Test Intervention + Contingency Management', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.', 'interventionNames': ['Behavioral: Connect2Test']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Contingency Management Alone', 'description': '$10 financial incentive for vaccination and $10 financial incentive for testing.', 'interventionNames': ['Behavioral: Connect2Test']}], 'interventions': [{'name': 'Connect2Test', 'type': 'BEHAVIORAL', 'otherNames': ['Motivational Enhancement'], 'description': 'Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients', 'armGroupLabels': ['Connect2Test Intervention + Contingency Management', 'Contingency Management Alone']}]}, 'contactsLocationsModule': {'locations': [{'zip': '97403', 'city': 'Eugene', 'state': 'Oregon', 'country': 'United States', 'facility': 'University of Oregon', 'geoPoint': {'lat': 44.05207, 'lon': -123.08675}}]}, 'ipdSharingStatementModule': {'url': 'https://radx-up.org/', 'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'ICF'], 'ipdSharing': 'YES', 'description': 'In line with funding requirements, we will share data with our data coordination center and the national institutes of health'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of Oregon', 'class': 'OTHER'}, 'collaborators': [{'name': 'National Institute on Drug Abuse (NIDA)', 'class': 'NIH'}], 'responsibleParty': {'type': 'SPONSOR'}}}}